This brand name is authorized in Nigeria.
The drug G-CLAV contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
544Y3D6MYH - AMOXICILLIN SODIUM
|
|
Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or more enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway of bactericidal peptidoglycan, which is an integral structural component of the bacterial cell wall. Inhibition of peptidoglycan synthesis leads to weakening of the cell wall, which is usually followed by cell lysis and death. |
|
2
|
UNII
Q42OMW3AT8 - CLAVULANATE POTASSIUM
|
|
Clavulanic acid is a beta-lactam structurally related to penicillins. It inactivates some beta-lactamase enzymes thereby preventing inactivation of amoxicillin. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-6068 | Tablet | G-CLAV 625 TABLET TAB 500 mg; 125 mg 2X7 | 32 CMS-PP-337499 G-CLAV 625 TABLET AMOXICILLIN 500MG & CLAVULANIC ACID 125MG USP AMOXICILLIN TIHYDRATE EQ TO AMOXICILLIN 500MG USP, CLAVULANTE POTASSIUM EQ TO CLAVULANIC ACID 125MP USP, MICROCRYSTALLINE CELLULOSE USP, CROSSPOVIDONE USP, COLLOIDAL SILICON DIOXIDE USP, MAGNESIUM STEARATE USP, INSTA MOIST SHIELD USP, METHYLENE CHLORIDE USP, ISOPROPYL ALCOHOL USP, PURIFIED TALC USP, TITANIUM DIOXIDE USP A4-6068 Drugs Imported Products 2X7 POM 1 6/19/2023 GREENLIFE PHARMACEUTICALS LIMITED, 35A, ASSOCIATION AVENUE, ILUPEJU, LAGOS 17378995 greenlife.regulatory@yahoo.com BROOKS LABORATORIES LTD, Village Kishanpura, Nalagarh Road,Baddi, Distt. solan, H.P.India, India | 31/10/2023 |
| A4-6099 | Powder for injection | G-Clav Injection INJ_PWD 1000 mg; 200 mg | Powder for solution for injection in a vial + 20 mL SWFI Each vial contains: Amoxicillin Sodium equiv. to Amoxicillin 1000 mg, Clavulanate Potassium equiv. to Clavulanic Acid 200 mg | 02/12/2021 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J01CR02 | Amoxicillin and enzyme inhibitor | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CR Combinations of penicillins, incl. beta-lactamase inhibitors |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-6068, A4-6099 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.